SS 31 - Breast Cancer 3: Refining Radiation in Early-Stage Breast Cancer: Personalization, Precision, and De-escalation

Presentations

• 08:00am - 08:10am PT

  Utilization of a Lumpectomy Bed Boost after Whole Breast Radiotherapy Does Not Improve Ipsilateral Breast Tumor Recurrence Risk in Patients with Ductal Carcinoma In-Situ Treated on Three NSABP Trials

  Speaker: Atif Khan, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 08:10am - 08:20am PT

  Phase I Pre-Operative Single Fraction Dose Escalation Ablative Stereotactic Partial Breast Irradiation (S-PBI) Trial for Early Stage Breast Cancer

  Speaker: Asal Rahimi, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas
• 08:30am - 08:40am PT

  Early-Stage Breast Cancer with Low Genomic Risk: Optimizing Adjuvant Therapy

  Speaker: David Miller, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 08:40am - 08:50am PT

  Prognostic Significance of Lymph Node Tumor Deposit Size in Early-Stage Breast Cancer

  Speaker: Diana Roth OBrien, MD - Memorial Sloan Kettering Cancer Center, New York
• 08:20am - 08:30am PT

  An Update of a Phase II Trial of Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-Risk Breast Cancer (UNIQUE)

  Speaker: Hao Jing, MD - CAMS, Beijing